Gastrointestinal Therapeutics Global Market Report 2025
상품코드:1810897
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
소화관 치료제 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 5.5%로 524억 1,000만 달러로 성장합니다. 예측 기간 중의 성장은 생물제제 및 표적치료제에 대한 수요 증가, 맞춤형 의료의 채택 확대, 병용요법에 대한 환자 선호도 증가, 미생물 표적치료에 대한 관심 증가, 항생제 관련 소화기 합병증 증가 등에 기인할 것으로 예측됩니다. 이 기간의 주요 동향으로는 내시경 장비의 기술 통합 발전, 마이크로바이옴 기반 치료법 개발, 디지털 헬스 및 원격 모니터링 활용, 치료법 개발에 멀티오믹스 데이터 통합, 산 억제 치료의 혁신 등을 들 수 있습니다.
염증성장질환의 유병률 증가는 향후 소화기 치료제 시장의 성장을 촉진할 것으로 예측됩니다. 염증성장질환(IBD)은 주로 크론병과 궤양성 대장염을 포함한 소화관 염증을 특징으로 하는 만성질환입니다. IBD 환자 증가는 장내 미생물에 대한 비정상적인 면역 반응을 유발하는 유전적 감수성과 관련이 있습니다. 소화관 치료제는 근본적인 염증을 표적으로 삼아 소화 기능을 조절하고 증상을 완화하여 환자의 예후를 개선합니다. 예를 들어 2023년 12월 영국의 비영리단체인 IBD 레지스트리(IBD Registry)는 2023년에 5,300명 이상의 염증성장질환 환자가 등록되며, 2022년에 비해 3,000명 이상 증가했다고 보고했습니다. 이처럼 염증성장질환의 유병률 증가가 소화기 치료제 시장을 촉진하고 있습니다.
소화기 치료제 시장의 주요 기업은 치료 효과와 환자의 복약 순응도를 높이기 위해 서방형(SR) 복합제 캡슐과 같은 혁신적인 치료제에 집중하고 있습니다. 서방형(SR) 복합제 캡슐은 여러 유효성분을 시간이 지남에 따라 점진적으로 방출하는 경구용 의약품으로, 약물 수준의 안정성을 보장하고 빈번한 투여의 필요성을 줄여줍니다. 예를 들어 2024년 6월, 인도 제약회사 Acmus Drugs and Pharmaceuticals Limited는 인도에서 위장병 치료제인 라베프라졸+레보설피리드 SR 캡슐을 출시했습니다. 이 제제는 위산을 낮추는 양성자 펌프 억제제인 라베프라졸과 장 운동 기능을 개선하는 프로키네틱 제제인 레보설피리드를 결합한 제제입니다. 속쓰림, 위산 역류, 복부 팽만감, 소화불량 등의 증상을 완화하고 위식도 역류증, 소화성 궤양, 관련 위장병 등에 자주 처방됩니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 소화관 치료제 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 용도 산업의 분석
세계의 소화관 치료제 시장 : 성장률 분석
세계의 소화관 치료제 시장 실적 : 규모와 성장, 2019-2024
세계의 소화관 치료제 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 소화관 치료제 : TAM(Total Addressable Market)
제6장 시장 세분화
세계의 소화관 치료제 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
OTC(Over-the-Counter) 소화관 치료제
처방전 기반 소화관 치료제
세계의 소화관 치료제 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구
정맥내
기타 투여 경로
세계의 소화관 치료제 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
염증성장질환
위식도 역류증
소화성 궤양
과민성대장증후군
기타 용도
세계의 소화관 치료제 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 약국
세계의 소화관 치료제 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
클리닉
외래 수술 센터
진단 검사실
기타 최종사용자
세계의 소화관 치료제 시장 : 서브 세분화, 시판 위장약(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
제산제
완하제
지사제
소화 효소
프로바이오틱스
H2 수용체 길항제
시메티콘 제품
세계의 소화관 치료제 시장 : 서브 세분화, 처방전에 기반한 소화기계 치료제(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
프로톤 펌프 저해제
H.헬리코박터 파일로리에 대한 항생제
아미노살리실산염
생물제제
코르티코스테로이드
면역억제제
항구토제
제7장 지역별·국가별 분석
세계의 소화관 치료제 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 소화관 치료제 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
소화관 치료제 시장 : 경쟁 구도
소화관 치료제 시장 : 기업 개요
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Novartis AG Overview, Products and Services, Strategy and Financial Analysis
Takeda Pharmaceutical Company Limited. Overview, Products and Services, Strategy and Financial Analysis
Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
Otsuka Holdings Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
Daiichi Sankyo Company Limited.
Bausch Health Companies Inc
Olympus Corporation
UCB S.A.
Eisai Co. Ltd.
Aurobindo Pharma Limited.
Dr. Reddy's Laboratories Limited.
Ironwood Pharmaceuticals Inc
Salix Pharmaceuticals Ltd.
Ferring Pharmaceuticals A/S
Jubilant Pharma Limited.
Sebela Pharmaceuticals Inc
Cosmo Pharmaceuticals N.V.
Tillotts Pharma AG
Mitsubishi Tanabe Pharma Corporation
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
소화관 치료제 시장 2029 : 새로운 기회를 제공하는 국가
소화관 치료제 시장 2029 : 새로운 기회를 제공하는 부문
소화관 치료제 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁사 전략
제36장 부록
KSA
영문 목차
영문목차
Gastrointestinal therapeutics encompass a variety of drugs, biologics, and treatment options aimed at preventing, managing, or curing disorders of the gastrointestinal system, which includes the esophagus, stomach, intestines, liver, pancreas, and gallbladder. These treatments address conditions like acid reflux, ulcers, irritable bowel syndrome, Crohn's disease, and gastrointestinal cancers.
The primary categories of gastrointestinal therapeutics include over-the-counter (OTC) and prescription-based products. OTC gastrointestinal therapeutics consist of non-prescription medications designed to alleviate common digestive problems such as heartburn, indigestion, gas, constipation, and diarrhea. These therapies can be administered via different routes, including oral and intravenous methods. They are used to treat various conditions such as inflammatory bowel disease, gastroesophageal reflux disease, peptic ulcer disease, and irritable bowel syndrome. Distribution of these products occurs through hospital pharmacies, retail pharmacies, online pharmacies, and more. End users range from hospitals and clinics to ambulatory surgical centers and diagnostic laboratories.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The gastrointestinal therapeutics market research report is one of a series of new reports from The Business Research Company that provides gastrointestinal therapeutics market statistics, including gastrointestinal therapeutics global market size, regional shares, competitors with gastrointestinal therapeutics market share, detailed gastrointestinal therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal therapeutics industry. The gastrointestinal therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The gastrointestinal therapeutics market size has grown strongly in recent years. It will grow from $39.99 billion in 2024 to $42.30 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. Growth during the historic period was driven by increased government healthcare spending, higher rates of early diagnosis, expanded awareness campaigns about gut health, a rise in lifestyle-related digestive disorders, and the adoption of multidisciplinary treatment methods.
The gastrointestinal therapeutics market size is expected to see strong growth in the next few years. It will grow to $52.41 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. Growth in the forecast period is expected to result from increasing demand for biologics and targeted treatments, greater adoption of personalized medicine, a growing patient preference for combination therapies, increased focus on microbiome-targeted treatments, and a rise in antibiotic-related gastrointestinal complications. Key trends during this period include advancements in technology integration for endoscopic devices, development of microbiome-based therapies, the use of digital health and remote monitoring, incorporation of multi-omics data in therapy development, and innovations in acid suppression treatments.
The increasing prevalence of inflammatory bowel diseases is expected to drive the growth of the gastrointestinal therapeutics market in the future. Inflammatory bowel disease (IBD) is a chronic illness characterized by inflammation of the digestive tract, mainly including Crohn's disease and ulcerative colitis. The rise in IBD cases is linked to genetic susceptibility, which leads to an abnormal immune response to gut microbes. Gastrointestinal therapeutics work by targeting the underlying inflammation, regulating digestive functions, and easing symptoms to improve patient outcomes. For example, in December 2023, the IBD Registry, a UK-based non-profit organization, reported that over 5,300 individuals with inflammatory bowel diseases were registered in 2023, showing an increase of more than 3,000 members compared to 2022. Thus, the growing incidence of inflammatory bowel diseases is boosting the gastrointestinal therapeutics market.
Leading companies in the gastrointestinal therapeutics market are focusing on innovative treatments, such as sustained-release (SR) fixed-dose combination capsules, aimed at enhancing treatment effectiveness and patient adherence. Sustained-release (SR) fixed-dose combination capsules are oral drugs that gradually release multiple active ingredients over time, ensuring stable drug levels and reducing the need for frequent dosing. For instance, in June 2024, Akums Drugs and Pharmaceuticals Limited, an India-based pharmaceutical manufacturer, introduced rabeprazole + levosulpiride SR capsules for gastrointestinal disorders in India. This formulation pairs rabeprazole, a proton pump inhibitor that lowers stomach acid, with levosulpiride, a prokinetic that improves gut motility. Together, they provide relief from symptoms like heartburn, acid reflux, bloating, and indigestion, and are commonly prescribed for conditions such as gastroesophageal reflux disease, peptic ulcers, and related gastrointestinal issues.
In April 2023, Merck and Co., Inc., a US pharmaceutical company, acquired Prometheus Biosciences, Inc. for $10.8 billion. This acquisition is intended to strengthen Merck's immunology pipeline by advancing precision therapies for inflammatory diseases, including ulcerative colitis and Crohn's disease. Prometheus Biosciences, Inc., based in the US, specializes in precision therapeutics for immune-mediated disorders, particularly those affecting the gastrointestinal system.
Major players in the gastrointestinal therapeutics market are Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited., Boehringer Ingelheim International GmbH, Otsuka Holdings Co. Ltd., Daiichi Sankyo Company Limited., Bausch Health Companies Inc, Olympus Corporation, UCB S.A., Eisai Co. Ltd., Aurobindo Pharma Limited., Dr. Reddy's Laboratories Limited., Ironwood Pharmaceuticals Inc, Salix Pharmaceuticals Ltd., Ferring Pharmaceuticals A/S, Jubilant Pharma Limited., Sebela Pharmaceuticals Inc, Cosmo Pharmaceuticals N.V., Tillotts Pharma AG, Mitsubishi Tanabe Pharma Corporation.
North America was the largest region in the gastrointestinal therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gastrointestinal therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the gastrointestinal therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The gastrointestinal therapeutics market consists of sales of acid suppressants, antiemetic agents, antispasmodics, digestive enzymes, and prebiotics and probiotics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Gastrointestinal Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on gastrointestinal therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for gastrointestinal therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastrointestinal therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product: Over-The-Counter Gastrointestinal Therapeutics; Prescription-Based Gastrointestinal Therapeutics
2) By Route Of Administration: Oral; Intravenous; Other Routes Of Administration
3) By Application: Inflammatory Bowel Disease; Gastroesophageal Reflux Disease; Peptic Ulcer Disease; Irritable Bowel Syndrome; Other Applications
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
5) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Diagnostic Laboratories; Other End-Users
3. Gastrointestinal Therapeutics Market Trends And Strategies
4. Gastrointestinal Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Gastrointestinal Therapeutics Growth Analysis And Strategic Analysis Framework
5.1. Global Gastrointestinal Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Gastrointestinal Therapeutics Market Growth Rate Analysis
5.4. Global Gastrointestinal Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Gastrointestinal Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Gastrointestinal Therapeutics Total Addressable Market (TAM)
6.1. Global Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Over-The-Counter Gastrointestinal Therapeutics
Prescription-Based Gastrointestinal Therapeutics
6.2. Global Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Other Routes Of Administration
6.3. Global Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inflammatory Bowel Disease
Gastroesophageal Reflux Disease
Peptic Ulcer Disease
Irritable Bowel Syndrome
Other Applications
6.4. Global Gastrointestinal Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Gastrointestinal Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Ambulatory Surgical Centers
Diagnostic Laboratories
Other End-Users
6.6. Global Gastrointestinal Therapeutics Market, Sub-Segmentation Of Over-The-Counter Gastrointestinal Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antacids
Laxatives
Anti-Diarrheal Agents
Digestive Enzymes
Probiotics
H2-Receptor Antagonists
Simethicone Products
6.7. Global Gastrointestinal Therapeutics Market, Sub-Segmentation Of Prescription-Based Gastrointestinal Therapeutics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Proton Pump Inhibitors
Antibiotics For H. pylori
Aminosalicylates
Biologics
Corticosteroids
Immunosuppressants
Antiemetics
7. Gastrointestinal Therapeutics Market Regional And Country Analysis
7.1. Global Gastrointestinal Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Gastrointestinal Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Gastrointestinal Therapeutics Market
9.1. China Gastrointestinal Therapeutics Market Overview
9.2. China Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Gastrointestinal Therapeutics Market
10.1. India Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Gastrointestinal Therapeutics Market
11.1. Japan Gastrointestinal Therapeutics Market Overview
11.2. Japan Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Gastrointestinal Therapeutics Market
12.1. Australia Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Gastrointestinal Therapeutics Market
13.1. Indonesia Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Gastrointestinal Therapeutics Market
14.1. South Korea Gastrointestinal Therapeutics Market Overview
14.2. South Korea Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Gastrointestinal Therapeutics Market
15.1. Western Europe Gastrointestinal Therapeutics Market Overview
15.2. Western Europe Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Gastrointestinal Therapeutics Market
16.1. UK Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Gastrointestinal Therapeutics Market
17.1. Germany Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Gastrointestinal Therapeutics Market
18.1. France Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Gastrointestinal Therapeutics Market
19.1. Italy Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Gastrointestinal Therapeutics Market
20.1. Spain Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Gastrointestinal Therapeutics Market
21.1. Eastern Europe Gastrointestinal Therapeutics Market Overview
21.2. Eastern Europe Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Gastrointestinal Therapeutics Market
22.1. Russia Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Gastrointestinal Therapeutics Market
23.1. North America Gastrointestinal Therapeutics Market Overview
23.2. North America Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Gastrointestinal Therapeutics Market
24.1. USA Gastrointestinal Therapeutics Market Overview
24.2. USA Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Gastrointestinal Therapeutics Market
26.1. South America Gastrointestinal Therapeutics Market Overview
26.2. South America Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Gastrointestinal Therapeutics Market
27.1. Brazil Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Gastrointestinal Therapeutics Market
28.1. Middle East Gastrointestinal Therapeutics Market Overview
28.2. Middle East Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Gastrointestinal Therapeutics Market
29.1. Africa Gastrointestinal Therapeutics Market Overview
29.2. Africa Gastrointestinal Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Gastrointestinal Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Gastrointestinal Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Gastrointestinal Therapeutics Market Competitive Landscape And Company Profiles
